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Abstract 
Background: Hyperactivity disorder is one of the most common 
psychiatric disorders that can contribute to negative consequences 
such as addiction in adolescence. The aim of this study was to 
determine the relationship between addiction and hyperactivity 
disorder in Shahroud city. 
Methods: This is a case-control study with a sample size of 240. The 
case group included methadone-treated addicted drug abusers in 
Shahroud addiction clinic and the control group including patients 
admitted to the surgical wards of Imam Hossein hospital with no 
addiction to any drugs. We used the Conges (CAAR-S:OV) short-acting 
diagnostic questionnaire of adolescents (CAARS) for collecting the 
information. SPSS21 was used for data analysis with the significance 
level being set at 0.05. 
Results: This study included 150 controls and 90 cases. The mean age 
of cases and controls was 36.97 ± 10.40 and 31.57 ± 10.46 years, 
respectively. Although the case and control were statistically different 
in restlessness-hyperactivity (Pvalue = 0.034), they did statistically 
differ regarding the presence of hyperactivity disorder (Pvalue = 0.911). 
Conclusions: Since only the subgroup of restlessness-hyperactivity in 
the two groups was significantly different (the value was greater for the 
control group), it can be argued that in the addicted persons 
restlessness-hyperactivity is partially reduced by opiate. 
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Introduction 
Hyperactivity disorder is one of the most common 
psychiatric disorders in children and adolescents worldwide,1,2 
which occurs as a developmental disorder in 8-3% of children 
and 4% of adults.3,4 The symptoms of this disorder can be due 
to the lack of attention, impulsivity, and hyperactivity in 
different ages, where the factors influencing this disorder can 
be various genetic and environmental factors.4,5 Since studies 
have shown that the impact of this disorder continues in 
adolescence and even adulthood in 60% of cases, hyperactivity 
disorder cannot be described as a childhood disorder.6,7 
Although this disorder is rarely diagnosed in adults, studies 
have shown that those who have had this disorder in childhood 
will be also affected in their adulthood.8 A meta-analysis study 
showed that the prevalence of hyperactivity disorder was 5.3% 
in childhood.9 Also, studies have reported that the prevalence of 
this disorder was 3.5% for ten American, European and Asian 
countries.6,10 The prevalence of this disorder in Iran is 10% to 
12%11-13 (in Mashhad, Shiraz and Sanandaj, 12.3%, 8.5%, and 
9%, respectively).14-16 
Genetic factors are one of the most important factors in the 
development of the disorder due to impaired neural growth and 
its function.17,18 The probability of transmission of 
hyperactivity disorder from parents to children is more than 40-
45%.18 It is estimated that 50-65% of children with this disorder 
will also experience some problems in their adolescence. 
Although the symptoms of hyperactivity disorder are almost 
constant throughout the life, with age, the response to treatment 
may change so that older people respond better to the 
treatment. This disorder can appear as hyperactivity by children 
and negligence, lack of control, as well as non-organization and 
management in adults.6 The most important outcomes of this 
disorder in adolescence include motor hyperactivity, 
negligence, extreme emotional response, alcohol consumption, 
dropout, low stimulation thresholds, sudden and severe anger, 
impulsiveness, plus a weekly correlated and dysfunctional 
relationship between instability and interpersonal relationships, 
job failure, difficulty in establishing friendly relationships, and 
financial problems.19,20 
Addiction, which is a major plight in today's societies, can 
be a common outcome of hyperactivity disorder in 
adolescence.21 Research has shown that this disorder is 
responsible for more than 65% of drug addicts.22 Early-onset of 
drug use is one of the most important signs in diagnosing this 
disorder.23 An American survey found that 20 to 30% of people 
with substance abuse had hyperactivity disorder.24 Studies have 
also shown that hyperactivity disorder is associated with the 
risk of increased drug intake and smoking.25,26 In these patients, 
smoking becomes a normal behavior, such that the age of 
smoking has decreased while the number of consumed 
cigarettes has increased. 
Considering that addiction is one of the most damaging 
factors affecting the community, this study was conducted to 
determine the relationship between drug dependence and 
hyperactivity disorder in Shahroud. 
Materials and Methods  
The present study is a case-control study carried out in 
2012 in Shahroud. In this study, the case group was selected 
from addicted men who were treated with methadone in one 
addiction treatment center in Shahroud city (Pardis clinic). 
Patients undergoing methadone treatment were included in the  
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study and the control group was selected from men without 
a history of drug addiction admitted to the surgical wards of 
Imam Hossein hospital (Shahroud city). No history of drug use 
in the control group was evaluated based on the biographies in 
their hospital records and a questionnaire. Patients with severe 
psychiatric disorders such as psychotic disorder, severe mental 
impairment, and antisocial personality disorder, those with a 
score of 8 or greater for the heterogeneity index and eventually 
the subjects not completing the questionnaire were excluded. 
The sample size was estimated to be 75 in each group 
concerning the 5% prevalence of hyperactivity disorder in the 
general population and 20% in drug users and considering the 
5% significance level. In order to enhance the power of the 
study, 150 patients in the control group and 90 patients in the 
case group were considered. 
To collect information, the Conges (CAARS-S: OV) short-
acting diagnostic questionnaire of the adolescent was used 
which is a reliable and valid 26-item questionnaire.7 To 
determine the content validity of the translation, the 
questionnaires were evaluated and some changed were made in 
the items based on the opinion of three emergency medicine, 
epidemiology, and psychology specialists with a history of 
teaching the addiction course. To determine the face validity, 
the questionnaire was filled by 10 patients and as a result, 
difficult, vague, and unrelated items were changed. The 
reliability of the questionnaire was calculated using Cronbach’s 
alpha. The Cronbach’s alpha was 0.89, suggesting it as 
desirable.  
The 26 items in the questionnaire ranged from zero to three 
scores, measuring four factors including memory problems, 
restlessness-hyperactivity, emotional instability-impulse, and 
problems with their general self-impression. The scores of each 
sub-scale were converted into T score using an appropriate 
normative table (T score has an average of 50 and a standard 
deviation of 10). The T score of greater than 65 is clinically 
important; the T score of more than 80 shows the severity of 
the problems and pathology of that area, while also suggesting 
an outbreak or exaggeration in the symptoms. 
Data were analyzed using SPSS21 software, where student-
t, X2 and Fisher's exact test were used. Significance level was 
set at 0.05. The study protocol was approved by the ethics 
committee of Shahroud university of medical sciences 
(IR.SHMU.REC.890.13) where written informed consent was 
taken from all the participants. The questionnaires given to the 
participants did not have any unique identifiers including 
marital status and the identity of the participants was delinked 
from their responses. 
Results 
In this study, 151 patients were in the case group and 83 
patients in the control group. All patients were chosen from 
men. The average age in the case and control group was 36 and 
31 (years), respectively. There was a significant difference 
between the ages of two groups (Pvalue = 0.001). Most of the 
patients in the case group had a lower educational level where 
the difference was significant (Pvalue = 0.01) (table1). 
Table 1. Educational status in case and control groups (Pvalue= 0.01) 





















































Two groups did not have a significant difference in the total 
score of Conners attitude of hyperactivity disorder (Pvalue = 
0.449). The scores of the subjects were examined in four sub-
scales of low attention, memory problem, restlessness-
hyperactivity, emotional instability–impulsivity, and problems 
with general imagination. There was a significant difference 
between the two groups (Pvalue = 0.034) in the restlessness-
hyperactivity sub-scales (Pvalue = 0.034) (table 2). 
Table 2. Converz score and its sub-scales in the studied groups 
Pvalue Mean ± S.D Group Variable 
0.449 
23.64 ± 15.13 Case 
Total score of Conners 
25.04 ± 12.30 Control 
0.598 
4.27 ± 3.94 Case 
Lack of attention - memory problem 
4.03 ± 3.01 Control 
0.034 
4.93 ± 3.60 Case 
Restless - hyperactivity 
5.97 ± 3.52 Control 
0.775 
4.26 ± 3.44 Case 
Emotional instability - impact 
4.14 ± 2.57 Control 
0.500 
4.55 ± 3.41 Case 
Problems with general imagination 
4.48 ± 3.04 Control 
Discussion 
In the present study, all of the patients were chosen from 
men, as they had better cooperation than women for cultural 
reasons. Most of the patients in the case group had a lower 
educational level and the difference was significant (Pvalue = 
0.01). This may or may not be due to addiction which has not been 
studied in this research. Restlessness-hyperactivity was 
significantly associated with drug use. Restlessness becomes 
more severe in the event of drug deprivation which is an 
indicator of hyperactivity in methadone-treated patients.  
The control group score in the subgroup of restlessness-
hyperactivity was lower than that of the case group, which can 
be attributed to the reduction in drug abuse. Berkeley and 
colleagues also found similar results in their study.5 
Fazilletpour and colleagues also obtained a positive and 
significant correlation between hyperactivity, scarcity, and 
addiction in their study.27 
As prospective cohorts, previous studies have tried to 
investigate the relationship between hyperactivity and the 
tendency to use drugs through following up those with 
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hyperactivity and the reporting the number of drug abusers.28,29 
In some studies, the disorder is considered to be the cause of 
addiction, while others consider addiction as the cause of this 
disorder.23,30,31 In this study, there was no significant 
relationship between hyperactivity disorder and addiction. For 
this reason, it can be stated that addiction does not engender 
hyperactivity disorder, but hyperactivity may be the cause of 
drug use tendency. Since in the present study, only the 
subgroup of restlessness-hyperactivity in the two groups was 
significantly different, these individuals may develop 
restlessness when they are deprived of drug use, which is an 
indicator of hyperactivity disorder. 
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